Mugglehead
Subscribe
Health & Science

Medical and Pharmaceutical

Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.

807 stories · latest Oct 11, 2026
Page 21
Why a Lack of Data Is a Big Problem for CBD

It's not hard to find anecdotes of how CBD has helped provide patients with pain relief, normally after exhausting all other options. The problem, however, is that there isn't a lot of data behind those claims and finding hard facts and numbers on the effectiveness of CBD is very difficult.

Stock NewsMar 5
Class Action Against Organigram Set to Go to Trial

In late 2016 and early 2017, Organigram Holdings Inc (TSXV:OGI) began voluntary recalls of its medical marijuana products after pesticides which were not permitted to be used on cannabis, as per the Pest Control Products Act, were detected. The recalls fell into hazard categories II and III, which suggested that at worst, there might be temporary side effects for affected customers...now here comes the lawsuits.

CanadaJan 21
Shoppers Drug Mart Launches Online Cannabis Site

Medical marijuana patients in Ontario can now make cannabis purchases online through Shoppers Drug Mart's new website. The website recently launched and is designed for patients and provides information for consumers interested in learning more about medical marijuana. Here's how it stacks up against the others.

Medical and PharmaceuticalJan 8
Are Drive-Thrus the Future for the Cannabis Industry?

Cannabis can be purchased in-store, online, and it can even be picked up in a drive-thru. For consumers in Vermont, the option is now available in Brattleboro. Ceres Natural Remedies sells hemp-derived cannabidiol (CBD) - which was recently legalized - and has opened the company's first drive-thru where consumers can pick up cannabis the same way they might get their fast food. While it's not the first one in the country, it's by no means prevalent just yet.

CBDJan 1
Tilray and Sandoz AG Team Up to Sell Medical Cannabis Around the World

Tilray Inc (NASDAQ:TLRY) shares jumped Tuesday as the Company announced it would be working with pharmaceutical company Sandoz AG to make medical marijuana products available around the globe. Tilray already has a presence in a dozen countries and this will help accelerate the company's incredible growth.

Medical and PharmaceuticalDec 19